Corcept Therapeutics (CORT)

Corcept Therapeutics

CORT

#3014

Rank

C$5.79 B

Marketcap

🇺🇸 USA

Country

$55.50

Share price

-3.19%

Change (1 day)

25.59%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Corcept Therapeutics - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year	P/B ratio	Change
2024-12-31	N/A	-100%
2023-12-31	6.61	51.66%
2022-12-31	4.36	-28.38%
2021-12-31	6.08	4.75%
2020-12-31	5.81	55.51%
2019-12-31	3.73	-32.97%
2018-12-31	5.57	-48.39%
2017-12-31	10.8	-44.6%
2016-12-31	19.5	-34%
2015-12-31	29.5	-132.88%
2014-12-31	-89.8	-688.73%
2013-12-31	15.3	560.05%
2012-12-31	2.31	-72.08%
2011-12-31	8.28	-37.09%
2010-12-31	13.2	67.34%
2009-12-31	7.86	161.86%
2008-12-31	3.00	-63.8%
2007-12-31	8.29	66.66%
2006-12-31	4.98	60.13%
2005-12-31	3.11	0.9%
2004-12-31	3.08
2003-12-31	N/A

P/B ratio for similar companies or competitors

Company	P/B ratio	differencediff.	Country
Johnson & Johnson JNJ	5.55	-22.66%	🇺🇸 USA
Bristol-Myers Squibb BMY	5.82	-18.81%	🇺🇸 USA
Novartis NVS	5.60	-21.86%	🇨🇭 Switzerland
Eli Lilly LLY	60.4	742.60%	🇺🇸 USA
Pfizer PFE	1.91	-73.36%	🇺🇸 USA
Merck MRK	6.81	-5.07%	🇺🇸 USA
Esperion Therapeutics ESPR	-0.9976	-113.91%	🇺🇸 USA
MannKind Corp MNKD	-8.16	-213.79%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	2.57	-64.14%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of September 2024 : 7.17